Solid Biosciences Inc.
SLDBNasdaqCIK 1707502HealthcareFiscal year ends Dec 31
Reports and events: 154 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1417:22 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-352656 |
| 2026-08-0617:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-338438 |
| 2026-08-0616:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-337935 |
| 2026-06-2418:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000183 |
| 2026-06-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-265804 |
| 2026-05-1216:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219337 |
| 2026-04-2316:03 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001193125-26-173642 |
| 2026-04-1016:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-151259 |
| 2026-03-1916:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-115928 |
| 2026-03-1718:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-029671 |
| 2026-03-1217:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-102489 |
| 2026-03-1116:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-102083 |
| 2026-03-1017:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-100348 |
| 2026-03-1016:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000070 |
| 2026-03-0616:36 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-096709 |
| 2025-11-0317:22 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-262818 |
| 2025-11-0317:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-262795 |
| 2025-08-1418:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-022028 |
| 2025-08-1216:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107279 |
| 2025-06-1316:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-086215 |
| 2025-05-1516:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-072792 |
| 2025-05-1516:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-072560 |
| 2025-04-2516:01 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001193125-25-096695 |
| 2025-03-0616:13 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034644 |
| 2025-02-2118:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-025036 |
| 2025-02-2116:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-005065 |
| 2025-02-2116:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-024858 |
| 2025-02-1816:52 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028691 |
| 2025-02-1807:07 ET | 8-K | 8.01 Other events | 0001193125-25-028146 |
| 2025-02-1806:55 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028123 |
| 2024-11-1419:59 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-259014 |
| 2024-11-0616:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122247 |
| 2024-08-1316:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096130 |
| 2024-06-1218:26 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-070940 |
| 2024-06-1120:43 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-159367 |
| 2024-06-1116:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-159143 |
| 2024-05-1507:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-060034 |
| 2024-04-2616:14 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001193125-24-118079 |
| 2024-03-1307:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-030508 |
| 2024-01-1217:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-007643 |
| 2024-01-1217:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-007632 |
| 2024-01-1117:24 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-003373 |
| 2024-01-1016:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-005969 |
| 2024-01-0807:24 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003882 |
| 2023-11-1507:59 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-277552 |
| 2023-11-0816:08 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061096 |
| 2023-08-1416:03 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-042371 |
| 2023-06-0916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-164486 |
| 2023-05-2216:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-150518 |
| 2023-05-1107:41 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020851 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.